Cardiac arrest systems of care are successfully coordinating community, emergency medical
services, and hospital efforts to improve the process of care for patients who have had a …

The use of extracorporeal membrane oxygenation (ECMO) support for cardiac and
respiratory failure has increased in recent years. Improvements in ECMO oxygenator and …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Background—Contemporary ventricular assist device therapy results in a high rate of
successful heart transplantation but is associated with bleeding, infections, and other …

Objectives: The objective of the study was to determine the prevalence of bleeding during
continuous-flow left ventricular assist device support and to identify potential mechanisms for …

Background Recommended structured clinical practices including implant technique, anti-
coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate …

Abstract Background: The HeartMate 3 left ventricular assist system (LVAS) is intended to
provide long-term support to patients with advanced heart failure. The centrifugal flow pump …

Background In this study we investigated gastrointestinal (GI) bleeding and its relationship to
arteriovenous malformations (AVMs) in patients with the continuous-flow HeartMate II (HMII) …

BACKGROUND: Bleeding is a major cause of morbidity in recipients of continuous-flow left
ventricular assist devices (CF-LVAD). A better understanding of the impact of CF-LVAD …

VADs), it is not surprising that bleeding and thrombosis are among the most common and
feared complications of this therapy, respectively. Although strides have been made in our …